Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07203079 · ClinicalTrials.gov registry record · Phase 4
Oral Versus Intravenous Acetaminophen in Lumbar Spine Surgery
A Phase 4 study, sponsored by Stanford University.
- Not yet
- Registry status
- Phase 4
- Development phase
- 180
- Enrollment target
NCT07203079: Clinical Trial Phase 4 study, sponsored by Stanford University.
NCT07203079 is a Phase 4 study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 180 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07203079, a Phase 4 study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 180 participants
- Enrollment target
Study Summary
The goal of this study is to compare whether oral or intravenous acetaminophen works better for pain control in patients undergoing lumbar spine fusion surgery
Primary Outcome
Mean pain intensity scores post-operatively using 11-point Numerical Rating Scale (NRS) (scale ranges from 0 to 10, and higher score means higher pain)
Interventions
- DRUG Placebo infusion
- DRUG Acetaminophen Oral Tablet
- DRUG placebo oral tablet
- DRUG Acetaminophen infusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2026-01 |
| Est. Completion | 2027-01 |
| Phase | Phase 4 |
What is known before NCT07203079 opens enrollment
NCT07203079 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (65% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo infusion is the first listed.
NCT07203079 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07203079 about?
NCT07203079 is a clinical study titled "Oral Versus Intravenous Acetaminophen in Lumbar Spine Surgery". The goal of this study is to compare whether oral or intravenous acetaminophen works better for pain control in patients undergoing lumbar spine fusion surgery
What is the current status of trial NCT07203079?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 180 participants. The study started on 2026-01. Estimated completion is 2027-01.
What interventions are being tested in trial NCT07203079?
The interventions under investigation include: Placebo infusion (DRUG), Acetaminophen Oral Tablet (DRUG), placebo oral tablet (DRUG), Acetaminophen infusion (DRUG).
Who is sponsoring clinical trial NCT07203079?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07203079's enrollment target sits among peer trials
180 466th of 2000 higher than 1,525 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia